Company: VREOF
Filing Date: 2025-03-21
Form Type: DEFM14C
Source: 0001140361-25-009815
Chunk: 87

Company: Vireo Growth Inc.
Filing Date: 2025-03-21
Form: DEFM14C
Chunk 87
---
 results of operations, condition (financial or otherwise), liabilities or assets of Wholesome and its subsidiaries (excluding Arches), taken as a whole, or (ii) on the ability of Wholesome to perform its obligations under the Wholesome Merger Agreement or to consummate the Wholesome Merger, or on the consummation of (whether by prevention or material delay) the Wholesome Merger and the other transactions contemplated by the Wholesome Merger Agreement; provided, however, that “Material Adverse Effect” shall not include any effect, event, development, occurrence, fact, condition or change, directly arising out of or attributable to: (a) changes in general business, economic or political conditions; (b) changes in conditions generally affecting the industries in which Wholesome and its subsidiaries (excluding Arches) operate; (c) any changes in financial or securities markets in general; (d) any national or international political, regulatory or social conditions, including acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof, pandemics, epidemics or states of emergency, whether declared or undeclared; (e) any “act of God,” including, but not limited to, weather, natural disasters and earthquakes; (f) any changes in applicable laws or accounting rules, including GAAP; (g) any action required or permitted by the Wholesome Merger Agreement; (h) the public announcement or pendency of the transactions contemplated by Wholesome Merger Agreement; or (i) any failure (in and of itself) by Wholesome and its subsidiaries (excluding Arches) to meet, with respect to any period or periods, any projections or forecasts, estimates of earnings or revenues or business plan (provided, that any effect, event, development, occurrence, fact, condition or change giving rise to or contributing to such failure may be deemed to constitute, or be taken into account in determining whether there has been a Material Adverse Effect); provided further, however, that any event, occurrence, fact, condition or change referred to in clauses (a) through (f) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has a disproportionate effect on Wholesome and its subsidiaries (excluding Arches) compared to other participants in the industries in which Wholesome and its subsidiaries (excluding